Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Diploma Share Price
  4. Diploma Share Regulatory News
  5. Change of Director responsibilities

Pin to quick picksDiploma Regulatory News (DPLM)

Diploma Information

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,200.00    5.00 (0.07%)
Bid:
7,205.00
Ask:
7,210.00
Spread: 5.00 (0.069%)
Market Cap: £9.65b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Change of Director responsibilities

Today 15:05

RNS Number : 0322L
Diploma PLC
03 July 2026
 

 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

 

 

 

3rd July 2026

 

 

CHANGE OF DIRECTOR RESPONSIBLITIES

Diploma PLC, the value-add solutions group, today announces changes to the composition of the Remuneration Committee.

 

Jennifer Ward will remain a member of the Remuneration Committee but, due to her other commitments, will step down as Chair from 6th July 2026. Katie Bickerstaffe, Senior Independent Director, will become interim Chair of the Remuneration Committee from this date and Ian El-Mokadem will join the Remuneration Committee.

 

This announcement is made in accordance with UK Listing Rule 6.4.6R.

 

Anna Lawrence

Group General Counsel & Company Secretary

Diploma PLC

 

 

For further information, please contact:

 

Diploma PLC -

 

+44 (0)20 7549 5700

Anna Lawrence, General Counsel & Company Secretary

Holly Gillis, Head of Investor Relations

 

 

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGGNFFVGVZM
12345678910
Date   Source Headline
3rd Jul 20263:05 pmRNSChange of Director responsibilities
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IBT
Int.biotech.
LSE
1.86%
MYI
Murray International
LSE
1.12%
IVPG
IVPG.L
LSE
0.00%
MIG
MIG.L
LSE
0.00%
BARC
Barclays
LSE
0.04%
Trending
ORCP
Oracle Power
LSE
-10.00%
QHE
Quantum Helium
LSE
9,981.97%
HEX
Helix Exploration
LSE
-7.88%
MPAL
Medpal AI
LSE
-8.75%
IMM
Immupharma
LSE
4.35%